Lucideon to Exhibit and Present at Making Pharma 2019
Lucideon will exhibit and present at Making Pharma 2019, which will be held between 30 April and 1 May, at the Ricoh Arena, Coventry, UK. Lucideon will be exhibiting on stand 327 and presenting a talk titled "Inorganic Abuse Deterrent Carrier for Opioid Drugs".
Lucideon provides product development, formulation and troubleshooting services to the pharmaceutical sector all over Europe and in the USA. Lucideon also develops its own platform technologies, including controlled release and abuse deterrence technologies as innovative delivery solutions for the pharmaceutical industry.
Making Pharma is an annual pharmaceutical exhibition and conference that runs over two days and welcomes more than 2,000 visitors and 200 exhibitors. One of Europe’s biggest pharmacy industry events, the exhibition provides a wide range of industry experts with the opportunity to meet, network and learn the latest trends and offerings in the sector.
Craig Donald, Head of Analytical Chemistry, Lucideon, said:
"We have serviced the pharmaceutical sector for many years at Lucideon, delivering a wide range of projects and developing unique methods for many of the largest names in the industry.
"As a growing and dynamic business that remains reactive to the current and future needs of the pharmaceutical industry we are always introducing new services and capabilities. Making Pharma will be a great platform for us to meet with some of the key industry movers and discuss their business and development requirements, and how Lucideon can help."
Dr Gilda Gasparini, Chemical Engineer, Lucideon, who will be presenting Lucideon's talk at Making Pharma added:
"My talk will focus on controlled release technologies with abuse deterrent properties, a hot topic in the pharma industry right now with the opioid crisis. I think the talk will hold a lot of interest for the pharmaceutical professionals in attendance at this event."
Lucideon partners with clients across the globe to support their materials challenges throughout the lifecycle of their products. Through expert consultancy, technology development, and testing and characterization services, Lucideon works as an extension to its clients' teams, providing quicker routes to market, competitive advantage, regulatory approvals, and game-changing materials science. With technical expertise, industry experience, and analytical and materials know-how, Lucideon works across a range of segments, including orthopaedics, vascular, dental, consumer healthcare, pharmaceutical, wound care, and medical devices.
To find out more about Making Pharma 2019 please visit www.makingpharma.com
01 February, 2019